Istvan Bitter - Publications

Semmelweis Egyetem, Hungary 
Pharmacy, Clinical Psychology

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Papp S, Tombor L, Kakuszi B, Balogh L, Réthelyi JM, Bitter I, Czobor P. Impaired early information processing in adult ADHD: a high-density ERP study. Bmc Psychiatry. 20: 292. PMID 32522183 DOI: 10.1186/s12888-020-02706-w  0.64
2020 Baradits M, Bitter I, Czobor P. Multivariate patterns of EEG microstate parameters and their role in the discrimination of patients with schizophrenia from healthy controls. Psychiatry Research. 288: 112938. PMID 32315875 DOI: 10.1016/j.psychres.2020.112938  0.64
2020 Kakuszi B, Szuromi B, Bitter I, Czobor P. Attention deficit hyperactivity disorder: Last in, first out - delayed brain maturation with an accelerated decline? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 34: 65-75. PMID 32279924 DOI: 10.1016/j.euroneuro.2020.03.011  0.64
2019 Bitter I, Bolyós C, Nagy M, Réthelyi J, Czobor P. [How we see the development of clinical trials from the investigators' side?] Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata. 34: 393-402. PMID 31767799  0.64
2019 Bitter I, Mohr P, Balogh L, Látalová K, Kakuszi B, Stopková P, Zmeškalová-Jelenová D, Pulay A, Czobor P. ADHD: a hidden comorbidity in adult psychiatric patients. Attention Deficit and Hyperactivity Disorders. 11: 83-89. PMID 30927233 DOI: 10.1007/s12402-019-00285-9  0.64
2018 Kakuszi B, Bitter I, Czobor P. Suicidal ideation in adult ADHD: Gender difference with a specific psychopathological profile. Comprehensive Psychiatry. 85: 23-29. PMID 29957374 DOI: 10.1016/j.comppsych.2018.06.003  0.64
2018 Baradits M, Kakuszi B, Bálint S, Fullajtár M, Mód L, Bitter I, Czobor P. Alterations in resting-state gamma activity in patients with schizophrenia: a high-density EEG study. European Archives of Psychiatry and Clinical Neuroscience. PMID 29569047 DOI: 10.1007/s00406-018-0889-z  0.64
2018 Tombor L, Kakuszi B, Papp S, Réthelyi J, Bitter I, Czobor P. Decreased resting gamma activity in adult Attention Deficit/Hyperactivity Disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-33. PMID 29457912 DOI: 10.1080/15622975.2018.1441547  0.64
2017 Balogh L, Kakuszi B, Papp S, Tombor L, Bitter I, Czobor P. Neural Correlates of Error Monitoring in Adult Attention Deficit Hyperactivity Disorder After Failed Inhibition in an Emotional Go/No-Go Task. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych161001. PMID 28464703 DOI: 10.1176/appi.neuropsych.16100183  0.64
2017 Németh G, Laszlovszky I, Czobor P, Szalai E, Szatmári B, Harsányi J, Barabássy Á, Debelle M, Durgam S, Bitter I, Marder S, Fleischhacker WW. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial. Lancet (London, England). PMID 28185672 DOI: 10.1016/S0140-6736(17)30060-0  0.64
2016 Czobor P, Kakuszi B, Németh K, Balogh L, Papp S, Tombor L, Bitter I. Electrophysiological indices of aberrant error-processing in adults with ADHD: a new region of interest. Brain Imaging and Behavior. PMID 27752922 DOI: 10.1007/s11682-016-9610-x  0.64
2016 Hargarter L, Bergmans P, Cherubin P, Keim S, Conca A, Serrano-Blanco A, Bitter I, Bilanakis N, Schreiner A. Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia. Expert Opinion On Pharmacotherapy. 1-11. PMID 27042990 DOI: 10.1080/14656566.2016.1174692  0.64
2016 Kakuszi B, Tombor L, Papp S, Bitter I, Czobor P. Altered response-preparation in patients with adult ADHD: A high-density ERP study. Psychiatry Research. 249: 57-66. PMID 27000308 DOI: 10.1016/j.pscychresns.2016.02.008  0.64
2016 Kakuszi B, Tombor L, Papp S, Bitter I, Czobor P. Altered response-preparation in patients with adult ADHD: A high-density ERP study Psychiatry Research - Neuroimaging. 249: 57-66. DOI: 10.1016/j.pscychresns.2016.02.008  0.64
2016 Pulay AJ, Bitter I, Papp S, Gulácsi L, Péntek M, Brodszky V, Hevér NV, Rencz F, Baji P. Exploring the Relationship between Quality of Life (EQ-5D) and Clinical Measures in Adult Attention Deficit Hyperactivity Disorder (ADHD) Applied Research in Quality of Life. 1-16. DOI: 10.1007/s11482-016-9467-6  0.64
2015 Bálint S, Bitter I, Czobor P. Neurobiological correlates of cognitive flexibility in ADHD - A systematic review of the literature | A kognitív rugalmasság neurobiológiai korrelátumainak vizsgálata ADHD-ban lrodalmi áttekintés Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 30: 363-371. PMID 26771696  0.64
2015 Wykes T, Haro JM, Belli SR, Obradors-Tarragó C, Arango C, Ayuso-Mateos JL, Bitter I, Brunn M, Chevreul K, Demotes-Mainard J, Elfeddali I, Evans-Lacko S, Fiorillo A, Forsman AK, Hazo JB, et al. Mental health research priorities for Europe. The Lancet. Psychiatry. PMID 26404415 DOI: 10.1016/S2215-0366(15)00332-6  0.64
2015 Bitter I, Fehér L, Tényi T, Czobor P. Treatment adherence and insight in schizophrenia Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 30: 18-26. PMID 25867885  0.64
2014 Haro JM, Ayuso-Mateos JL, Bitter I, Demotes-Mainard J, Leboyer M, Lewis SW, Linszen D, Maj M, McDaid D, Meyer-Lindenberg A, Robbins TW, Schumann G, Thornicroft G, Van Der Feltz-Cornelis C, Van Os J, et al. ROAMER: roadmap for mental health research in Europe. International Journal of Methods in Psychiatric Research. 23: 1-14. PMID 24375532 DOI: 10.1002/mpr.1406  0.64
2014 Katona L, Czobor P, Bitter I. Real-world effectiveness of antipsychotic monotherapy vs. polypharmacy in schizophrenia: to switch or to combine? A nationwide study in Hungary. Schizophrenia Research. 152: 246-54. PMID 24275583 DOI: 10.1016/j.schres.2013.10.034  0.64
2014 Schumann G, Binder EB, Holte A, de Kloet ER, Oedegaard KJ, Robbins TW, Walker-Tilley TR, Bitter I, Brown VJ, Buitelaar J, Ciccocioppo R, Cools R, Escera C, Fleischhacker W, Flor H, et al. Stratified medicine for mental disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 5-50. PMID 24176673 DOI: 10.1016/j.euroneuro.2013.09.010  0.64
2013 Szily E, Bitter I. Designer drugs in psychiatric practice - A review of the literature and the recent situation in hungary | quot;designer" drogok a pszichiátriai gyakorlatban - Irodalmi áttekintés és a magyarországi helyzet elemzése Neuropsychopharmacologia Hungarica. 15: 223-231. PMID 24380963  0.64
2013 Gazdag G, Takács R, Tolna J, Iványi Z, Ungvari GS, Bitter I. Electroconvulsive therapy in a Hungarian academic centre (1999-2010) Psychiatria Danubina. 25: 366-370. PMID 24247048  0.64
2013 Komlósi S, Csukly G, Stefanics G, Czigler I, Bitter I, Czobor P. Fearful face recognition in schizophrenia: An electrophysiological study Schizophrenia Research. 149: 135-140. PMID 23870809 DOI: 10.1016/j.schres.2013.06.044  0.64
2013 Szuromi B, Bitter I, Czobor P. Functional impairment in adults positively screened for attention-deficit hyperactivity disorder: The role of symptom presentation and executive functioning Comprehensive Psychiatry. 54: 974-981. PMID 23684546 DOI: 10.1016/j.comppsych.2013.04.002  0.64
2013 Réthelyi JM, Benkovits J, Bitter I. Genes and environments in schizophrenia: The different pieces of a manifold puzzle Neuroscience and Biobehavioral Reviews. 37: 2424-2437. PMID 23628741 DOI: 10.1016/j.neubiorev.2013.04.010  0.64
2013 Bitter I, Katona L, Zámbori J, Takács P, Fehér L, Diels J, Bacskai M, Lang Z, Gyáni G, Czobor P. Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: a nationwide study in Hungary. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1383-90. PMID 23477752 DOI: 10.1016/j.euroneuro.2013.02.003  0.64
2013 Kluge M, Hegerl U, Sander C, Dietzel J, Mergl R, Bitter I, Demyttenaere K, Gusmão R, Gonzalez-Pinto A, Perez-Sola V, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, et al. Methylphenidate in mania project (MEMAP): Study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate Bmc Psychiatry. 13. PMID 23446109 DOI: 10.1186/1471-244X-13-71  0.64
2013 Czobor P, Volavka J, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Insight and hostility as predictors and correlates of nonadherence in the European First Episode Schizophrenia Trial. Journal of Clinical Psychopharmacology. 33: 258-61. PMID 23422388 DOI: 10.1097/JCP.0b013e3182856886  0.64
2013 Simon V, Czobor P, Bitter I. Is ADHD severity in adults associated with the lifetime prevalence of comorbid depressive episodes and anxiety disorders? European Psychiatry. 28: 308-314. PMID 22986127 DOI: 10.1016/j.eurpsy.2012.05.002  0.64
2013 Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS. Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 196-204. PMID 22647933 DOI: 10.1016/j.euroneuro.2012.04.019  0.64
2012 Bitter I, Kurimay T. State of psychiatry in Hungary International Review of Psychiatry. 24: 307-313. PMID 22950769 DOI: 10.3109/09540261.2012.694856  0.64
2012 Bitter I, Angyalosi A, Czobor P. Pharmacological treatment of adult ADHD Current Opinion in Psychiatry. 25: 529-534. PMID 22801362 DOI: 10.1097/YCO.0b013e328356f87f  0.64
2012 Vassos E, Steinberg S, Cichon S, Breen G, Sigurdsson E, Andreassen OA, Djurovic S, Morken G, Grigoroiu-Serbanescu M, Diaconu CC, Czerski PM, Hauser J, Babadjanova G, Abramova LI, Mühleisen TW, ... ... Bitter I, et al. Replication study and meta-analysis in European samples supports association of the 3p21.1 locus with bipolar disorder. Biological Psychiatry. 72: 645-50. PMID 22560537 DOI: 10.1016/j.biopsych.2012.02.040  0.64
2012 Baran B, Bitter I, Ungvari GS, Gazdag G. The birth of convulsive therapy revisited: a reappraisal of László Meduna's first cohort of patients. Journal of Affective Disorders. 136: 1179-82. PMID 22230354 DOI: 10.1016/j.jad.2011.11.045  0.64
2012 Möller HJ, Bitter I, Bobes J, Fountoulakis K, Höschl C, Kasper S. Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression. European Psychiatry : the Journal of the Association of European Psychiatrists. 27: 114-28. PMID 22119161 DOI: 10.1016/j.eurpsy.2011.08.002  0.64
2012 Simon Z, Peragovics A, Vigh-Smeller M, Csukly G, Tombor L, Yang Z, Zahoránszky-Kohalmi G, Végner L, Jelinek B, Hári P, Hetényi C, Bitter I, Czobor P, Málnási-Csizmadia A. Drug effect prediction by polypharmacology-based interaction profiling. Journal of Chemical Information and Modeling. 52: 134-45. PMID 22098080 DOI: 10.1021/ci2002022  0.64
2012 Réthelyi JM, Czobor P, Polgár P, Mersich B, Bálint S, Jekkel E, Magyar K, Mészáros A, Fábián A, Bitter I. General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 262: 107-15. PMID 21792534 DOI: 10.1007/s00406-011-0224-4  0.64
2011 Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST). The Journal of Clinical Psychiatry. 72: 955-61. PMID 21824456 DOI: 10.4088/JCP.10m06529  0.64
2011 Steinberg S, de Jong S, Andreassen OA, Werge T, Børglum AD, Mors O, Mortensen PB, Gustafsson O, Costas J, Pietiläinen OP, Demontis D, Papiol S, Huttenlocher J, Mattheisen M, ... ... Bitter I, et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Molecular Genetics. 20: 4076-81. PMID 21791550 DOI: 10.1093/hmg/ddr325  0.64
2011 Bitter I, Filipovits D, Czobor P. Adverse reactions to duloxetine in depression Expert Opinion On Drug Safety. 10: 839-850. PMID 21545241 DOI: 10.1517/14740338.2011.582037  0.64
2011 Szuromi B, Czobor P, Komlósi S, Bitter I. P300 deficits in adults with attention deficit hyperactivity disorder: A meta-analysis Psychological Medicine. 41: 1529-1538. PMID 20961477 DOI: 10.1017/S0033291710001996  0.64
2011 Steinberg S, Mors O, Børglum AD, Gustafsson O, Werge T, Mortensen PB, Andreassen OA, Sigurdsson E, Thorgeirsson TE, Böttcher Y, Olason P, Ophoff RA, Cichon S, Gudjonsdottir IH, Pietiläinen OP, ... ... Bitter I, et al. Expanding the range of ZNF804A variants conferring risk of psychosis. Molecular Psychiatry. 16: 59-66. PMID 20048749 DOI: 10.1038/mp.2009.149  0.64
2010 Simon Z, Vigh-Smeller M, Peragovics A, Csukly G, Zahoránszky-Kohalmi G, Rauscher AA, Jelinek B, Hári P, Bitter I, Málnási-Csizmadia A, Czobor P. Relating the shape of protein binding sites to binding affinity profiles: is there an association? Bmc Structural Biology. 10: 32. PMID 20923553 DOI: 10.1186/1472-6807-10-32  0.64
2010 Stubnya G, Nagy Z, Lammers CH, Rihmer Z, Bitter I. Deinstitutionalization in Europe: two recent examples from Germany and Hungary. Psychiatria Danubina. 22: 406-12. PMID 20856183  0.64
2010 Inczédy-Farkas G, Benkovits J, Balogh N, Almos P, Scholtz B, Zahuczky G, Török Z, Nagy K, Réthelyi J, Makkos Z, Kassai-Farkas A, Egerházy A, Tuzko J, Janka Z, Bitter I, et al. [SCHIZOBANK - The Hungarian national schizophrenia biobank and its role in schizophrenia research and in personalized medicine]. Orvosi Hetilap. 151: 1403-8. PMID 20719713 DOI: 10.1556/OH.2010.28943  0.64
2010 Bitter I, Treuer T, Dilbaz N, Oyffe I, Ciorabai EM, Gonzalez SL, Ruschel S, Salburg J, Dyachkova Y. Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study World Journal of Biological Psychiatry. 11: 894-903. PMID 20653494 DOI: 10.3109/15622975.2010.505663  0.64
2010 Mohr P, Bitter I, Constant E, Jakovljević M, Jarema M, Pecenak J, Seifritz E, Švestka J, Sartorius N. Myth and reality of pragmatic trials Psychiatria Danubina. 22: 2-3. PMID 20305584  0.64
2010 Réthelyi JM, Bakker SC, Polgár P, Czobor P, Strengman E, Pásztor PI, Kahn RS, Bitter I. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 792-801. PMID 19937977 DOI: 10.1002/ajmg.b.31049  0.64
2010 Bitter I, Simon V, Bálint S, Mészáros A, Czobor P. How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample European Archives of Psychiatry and Clinical Neuroscience. 260: 287-296. PMID 19806424 DOI: 10.1007/s00406-009-0076-3  0.64
2009 Stubnya G, Nagy Z, Bagdy G, Rihmer Z, Molnár MJ, Harmatta J, Kovács GG, Perczel Forintos D, Simon L, Bitter I. [The way out from crisis--from the closing of the National Psychiatric and Neurologic Institute (OPNI) to Semmelweis University]. Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 24: 193-204. PMID 19794227  0.64
2009 Mészáros A, Czobor P, Bálint S, Komlósi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): A meta-analysis International Journal of Neuropsychopharmacology. 12: 1137-1147. PMID 19580697 DOI: 10.1017/S1461145709990198  0.64
2009 Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietiläinen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, ... ... Bitter I, et al. Common variants conferring risk of schizophrenia. Nature. 460: 744-7. PMID 19571808 DOI: 10.1038/nature08186  0.64
2009 Gazdag G, Bitter I, Ungvari GS, Baran B. Convulsive therapy turns 75. The British Journal of Psychiatry : the Journal of Mental Science. 194: 387-8. PMID 19407263 DOI: 10.1192/bjp.bp.108.062547  0.64
2009 Simon V, Czobor P, Bálint S, Mészáros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis British Journal of Psychiatry. 194: 204-211. PMID 19252145 DOI: 10.1192/bjp.bp.107.048827  0.64
2009 Gazdag G, Bitter I, Ungvari GS, Baran B, Fink M. László Meduna's pilot studies with camphor inductions of seizures: the first 11 patients. The Journal of Ect. 25: 3-11. PMID 19209069 DOI: 10.1097/YCT.0b013e31819359fc  0.64
2009 Bálint S, Czobor P, Komlósi S, Mészáros A, Simon V, Bitter I. Attention deficit hyperactivity disorder (ADHD): Gender- and age-related differences in neurocognition Psychological Medicine. 39: 1337-1345. PMID 18713489 DOI: 10.1017/S0033291708004236  0.64
2008 Baran B, Bitter I, Ungvári GS, Nagy Z, Gazdag G. [The birth of biological therapy in Hungary: the story of László Meduna's first patient receiving convulsive therapy]. Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 23: 366-75. PMID 19129553  0.64
2008 Bálint S, Czobor P, Mészáros A, Simon V, Bitter I. Neuropsychological impairments in adult attention deficit hyperactivity disorder: a literature review | A felnottkori figyelemhiányos/hiperaktivitás-zavarban tapasztalható neuropszichológial deficit: irodalmi áttekintés Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 23: 324-335. PMID 19129549  0.64
2008 Komlósi S, Czobor P, Bálint S, Bitter I. The relationship between cognition and functional outcome in schizophrenia | A szkizofréniában tapasztalható kognitív deficit osszefüggése a mindennapi funkcióképességgel Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 23: 166-176. PMID 18956623  0.64
2008 Réthelyi J, Polgár P, Czobor P, Bitter I. Recent advances in the genetics of schizophrenia and the practical implications of the results | A szkizofrénia genetikai hátterére irányuló kutatások ujabb eredményei es ezek alkalmazási lehetoségei. Irodalmi osszefoglalás Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 23: 152-165. PMID 18956622  0.64
2008 Baran B, Bitter I, Ungvari GS, Nagy Z, Gazdag G. The beginnings of modern psychiatric treatment in Europe. Lessons from an early account of convulsive therapy. European Archives of Psychiatry and Clinical Neuroscience. 258: 434-40. PMID 18504632 DOI: 10.1007/s00406-008-0816-9  0.64
2008 Farkas M, Polgár P, Kelemen O, Réthelyi J, Bitter I, Myers CE, Gluck MA, Kéri S. Associative learning in deficit and nondeficit schizophrenia. Neuroreport. 19: 55-8. PMID 18281892 DOI: 10.1097/WNR.0b013e3282f2dff6  0.64
2008 Baran B, Bitter I, Fink M, Gazdag G, Shorter E. Károly Schaffer and his school: the birth of biological psychiatry in Hungary, 1890-1940. European Psychiatry : the Journal of the Association of European Psychiatrists. 23: 449-56. PMID 18078742 DOI: 10.1016/j.eurpsy.2007.10.003  0.64
2008 Bitter I, Treuer T, Dyachkova Y, Martenyi F, McBride M, Ungvari GS. Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study European Neuropsychopharmacology. 18: 170-180. PMID 17884390 DOI: 10.1016/j.euroneuro.2007.08.001  0.64
2008 Polgár P, Farkas M, Nagy O, Kelemen O, Réthelyi J, Bitter I, Myers CE, Gluck MA, Kéri S. How to find the way out from four rooms? The learning of "chaining" associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophrenia Research. 99: 200-7. PMID 17693060 DOI: 10.1016/j.schres.2007.06.027  0.64
2007 Polgár P, Farkas M, Nagy O, Kelemen O, Réthelyi J, Bitter I, Myers CE, Gluck MA, Kéri S. [Learning cognitive skills in depression: the effect of context-change]. Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 22: 271-5. PMID 18167422  0.64
2007 Mészáros A, Czobor P, Bálint S, Simon V, Bitter I. Pharmacotherapy of adult Attention Deficit/Hyperactivity Disorder (ADHD): a systematic review | A felnottkori figyelemhiányos/hiperaktivitás zavar (ADHD) gyógyszeres kezelésének hatékonysága: irodalmi áttekintés Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 22: 259-270. PMID 18167421  0.64
2007 Gazdag G, Baran B, Bitter I, Ungvári GS, Gerevich J. Regressive and intensive methods of electroconvulsive therapy: a brief historical note. The Journal of Ect. 23: 229-32. PMID 18090693 DOI: 10.1097/yct.0b013e3181593d75  0.64
2007 Pethõ B, Tusnády G, Vargha A, Tolna J, Farkas M, Vizkeleti G, Tóth A, Szilágyi A, Bitter I, Kelemen A, Czobor P. Validity of reliability: comparison of interrater reliabilities of psychopathological symptoms. The Journal of Nervous and Mental Disease. 195: 606-13. PMID 17632252 DOI: 10.1097/NMD.0b013e318093f45d  0.64
2007 Simon V, Czobor P, Bálint S, Mészáros A, Murai Z, Bitter I. Detailed review of epidemiologic studies on adult Attention Deficit/Hyperactivity Disorder (ADHD) | A felnôttkori Figyelemhiányos/Hiperaktivitási Zavar (Attention Deficit/Hyperactivity Disorder--ADHD) epidemiológiai vizsgálatainak részletes áttekintése Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 22: 4-19. PMID 17558040  0.64
2007 Kelemen O, Nagy O, Mátyássy A, Bitter I, Benedek G, Vidnyánszky Z, Kéri S. How well do patients with schizophrenia track multiple moving targets? Neuropsychology. 21: 319-25. PMID 17484595 DOI: 10.1037/0894-4105.21.3.319  0.64
2007 Švestka J, Bitter I. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders Neuroendocrinology Letters. 28: 95-116. PMID 17262005  0.64
2006 Gazdag G, Bitter I, Gerevich J, Ungvári G. Chapters from the history of biological psychiatry: efforts made to increase the efficacy of electroconvulsive therapy | Fejezetek a biológiai pszichiátria történetébol: az elektrokonvulzív kezelés hatékonyságának fokozására tett kísérletek Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata. 21: 351-359. PMID 17297197  0.64
2006 Bartkó G, Trixler M, Bitter I, Degrell I, Füredi J, Faludi G. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics]. Neuropsychopharmacologia Hungarica : a Magyar PszichofarmakolóGiai EgyesüLet Lapja = Official Journal of the Hungarian Association of Psychopharmacology. 8: 201-9. PMID 17211055  0.64
2006 Ungvári SG, Gazdag G, Bitter I, Gerevich J. The beginnings of modern biological psychiatry in Hungary: the atropine coma. A historical overview | A modern magyar biológiai pszichiátria kezdetei: az atropin kóma. Történeti attekintés Neuropsychopharmacologia Hungarica : a Magyar PszichofarmakolóGiai EgyesüLet Lapja = Official Journal of the Hungarian Association of Psychopharmacology. 8: 79-84. PMID 17073216  0.64
2006 Füredi J, Mohr P, Swingler D, Bitter I, Gheorghe MD, Hotujac L, Jarema M, Kocmur M, Koychev GI, Mosolov SN, Pecenak J, Rybakowski J, Svestka J, Sartorius N. Psychiatry in selected countries of Central and Eastern Europe: An overview of the current situation Acta Psychiatrica Scandinavica. 114: 223-231. PMID 16968359 DOI: 10.1111/j.1600-0447.2006.00804.x  0.64
2006 Jones RM, Thompson C, Bitter I. A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania. European Psychiatry : the Journal of the Association of European Psychiatrists. 21: 1-9. PMID 16487905 DOI: 10.1016/j.eurpsy.2005.02.002  0.64
2006 Kasper S, Lowry AJ, Hodge A, Bitter I, Dossenbach M. Tardive dyskinesia: Analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America Schizophrenia Research. 81: 139-143. PMID 16253478 DOI: 10.1016/j.schres.2005.07.032  0.64
2006 Treuer T, Anders M, Bitter I, Dobre G, Pecenak J, Dyachkova Y, Harrison G, O'Mahoney J. Effectiveness and tolerability of schizophrenia treatment in Central and Eastern Europe: Results after 1 year from a prospective, observational study (IC-SOHO) International Journal of Psychiatry in Clinical Practice. 10: 78-90. DOI: 10.1080/13651500500409663  0.64
2005 Bitter I. Antipsychotic treatment and metabolic syndrome. Consensus meeting of the Metabolic Working Group of the Hungarian Diabetes Society and the Hungarian Psychiatric Collegium | Antipszichotikus terápia és metabolikus szindróma Psychiatria Hungarica : a Magyar PszichiáTriai TáRsasáG TudomáNyos FolyóIrata.. 20: 312-315. PMID 16462008  0.64
2005 Gazdag G, Bitter I, Ungvári G, Gerevich J. Atropine coma: A historical note Journal of Ect. 21: 203-206. PMID 16301877 DOI: 10.1097/01.yct.0000180041.13962.e4  0.64
2005 Bitter I, Czobor P, Dossenbach M, Volavka J. Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: A prospective naturalistic study (IC-SOHO) European Psychiatry. 20: 403-408. PMID 16084068 DOI: 10.1016/j.eurpsy.2005.01.009  0.64
2005 Bitter I, Basson BR, Dossenbach MR. Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients International Clinical Psychopharmacology. 20: 19-21. PMID 15602111 DOI: 10.1097/00004850-200501000-00004  0.64
2004 Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 457-70. PMID 15589385 DOI: 10.1016/j.euroneuro.2004.01.002  0.64
2004 Bitter I. Treatment of schizophrenia | A szkizofrénia kezelése Orvosi Hetilap. 145: 1281-1283. PMID 15264758  0.64
2004 Dossenbach M, Erol A, Kessaci MEM, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I. Effectiveness of antipsychotic treatments for schizophrenia: Interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol Journal of Clinical Psychiatry. 65: 312-321. PMID 15096069 DOI: 10.4088/JCP.v65n0305  0.64
2004 Bitter I. Modern pharmacotherapy of schizophrenia | A szkizofrénia modern gyógyszeres kezelése Orvosi Hetilap. 145: 105-109. PMID 15027331  0.64
2004 Bitter I, Dossenbach MR, Brook S, Feldman PD, Metcalfe S, Gagiano CA, Füredi J, Bartko G, Janka Z, Banki CM, Kovacs G, Breier A. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 173-80. PMID 14687871 DOI: 10.1016/j.pnpbp.2003.09.033  0.64
2004 MacIulis V, Bitter I, Milasiunas R, Dembinskas A, Radavicius L, Kaunas A, Dossenbach M, Walker D. Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study Current Therapeutic Research - Clinical and Experimental. 65: 57-69. DOI: 10.1016/S0011-393X(04)90005-7  0.64
2003 Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 48: 716-21. PMID 14733451  0.64
2003 Balázs J, Lecrubier Y, Csiszér N, Koszták J, Bitter I. Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: Importance of the first depressive episodes and of bipolar II diagnoses Journal of Affective Disorders. 76: 113-119. PMID 12943940 DOI: 10.1016/S0165-0327(02)00084-8  0.64
2003 Bitter I, Chou JC, Ungvari GS, Tang WK, Xiang Z, Iwanami A, Gaszner P. Prescribing for inpatients with schizophrenia: an international multi-center comparative study. Pharmacopsychiatry. 36: 143-9. PMID 12905100 DOI: 10.1055/s-2003-41199  0.64
1992 Volavka J, Cooper T, Czobor P, Bitter I, Meisner M, Laska E, Gastanaga P, Krakowski M, Chou JC, Crowner M. Haloperidol blood levels and clinical effects. Archives of General Psychiatry. 49: 354-61. PMID 1586270 DOI: 10.1001/archpsyc.1992.01820050018002  0.64
Show low-probability matches.